Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2020

Aug 07, 2020

SELL
$9.02 - $15.12 $15,703 - $26,323
-1,741 Closed
0 $0
Q1 2020

May 04, 2020

SELL
$7.14 - $16.86 $285 - $674
-40 Reduced 2.25%
1,741 $19,000
Q4 2019

Feb 04, 2020

BUY
$13.08 - $17.43 $5,742 - $7,651
439 Added 32.71%
1,781 $26,000
Q3 2019

Nov 12, 2019

BUY
$8.65 - $14.81 $11,608 - $19,875
1,342 New
1,342 $20,000

Others Institutions Holding VRCA

About Verrica Pharmaceuticals Inc.


  • Ticker VRCA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,094,100
  • Market Cap $327M
  • Description
  • Verrica Pharmaceuticals Inc., a dermatology therapeutics company, develops and commercializes treatments for people with skin diseases in the United States. The company's lead product candidate includes VP-102 for the treatment of molluscum contagiosum; that has completed Phase II clinical trial for the treatment of external genital warts; and w...
More about VRCA
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.